People in India are still wary of organ transplants. So, there is an urgent need of increased public awareness.
Govt committed to supporting pharma companies with industry-friendly policies
HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA in the United States
Lacosamide Injection is used to treat partial-onset seizures.
Companies finalize termination with an agreed-upon settlement fee of $55M to be paid to Akebia
The total covered market size of four brands – Z&D, Pediclory, Pecef & Ezinapi combined is Rs 1800 crores
The over-the-counter market has long been an important segment of Glenmark’s portfolio around the world
The research here will mainly concentrate on the manufacturing process of biopharmaceuticals, especially in the area of advanced medicines, as well as the fermentation-based manufacture of ingredients for foods and food supplements
First and only PARP inhibitor to improve invasive disease-free survival in patients
By applying digital technologies, pharma companies can significantly improve their operational and decision-making capabilities
Subscribe To Our Newsletter & Stay Updated
